Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives

NCT07071389 is registered in ClinicalTrials.gov with Lo.Li.Pharma s.r.l as lead sponsor.

NCT NCT07071389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07071389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives
Lead sponsor
Lo.Li.Pharma s.r.l
Phase
Not applicable
Overall status
Withdrawn
Start date
January 8, 2018
Completion date
December 21, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contraception